Posted:
6/10/2026, 10:11:43 PM
Location(s):
Massachusetts, United States ⋅ Cambridge, Massachusetts, United States
Experience Level(s):
Senior
Field(s):
Business & Strategy
About This Role
The Associate Director, Rare Disease Market Access Strategy will support development and execution of MA&R strategy for SMA and ALS, including the development of payer messaging, pricing & contracting strategy, coordination across all other MA&R functions, and alignment with the Rare Disease Franchise. You will be responsible for execution and pulling through aligned MA&R strategies. This role will report to the Director of Rare Disease Access Strategy, who is responsible for SMA and ALS access strategy in US MA&R.
What You’ll Do
Support development and execution of comprehensive market access strategies to support the SMA and ALS brands across commercial and government payer segments.
Support cross-functional planning and execution across all MA&R functions (including Payer Insights, Trade & Distribution, Patient Access, and National & Regional Account Teams) to ensure alignment with approved strategies
Coordinate and align with the Rare Disease Franchise on overall strategy as well as internal and external messaging.
Deliver impactful value propositions, messaging, and promotional materials (both branded and unbranded) tailored to key customer segments (e.g., plans, PBMs, GPOS, IDNs)
Execute on pull-through activities to ensure access optimization
Support work with Medical, HEOR, Global V&A in the generation of evidence to support access strategy
Work closely with Brand, legal, and finance in the development of contracting strategy to align with market dynamics and brand goals.
Develop pricing and innovative contracting strategies (e.g., value-based contracts)
Work with cross-functional teams to model scenario-based business cases to support key contracting recommendations to senior leadership
Research, compile, analyze, and assess market landscape data/trends to develop customized solutions that maximize patient access
Support development of Free Drug and co-pay support strategies
Support development of SP and SD strategies to optimize patient access
Execute and support training of MA&R RADs and NADs in alignment with approved strategies and materials
Support initiatives to evaluate MA&R performance in support of the Rare Disease Franchise
Support multiple cross functional teams in various projects as a market access expert (e.g., gross-to-net workstreams, forecasting, long-range planning, etc.)
Support pipeline activities, including Biogen’s pipeline assets for the SMA and ALS populations
Who You Are
You are a proactive market access expert with strong communication and analytic skills with deep expertise in the US healthcare system.
Required Skills
BA, BS or equivalent required, MBA preferred
7+ years of pharmaceutical, biopharma industry experience, including direct responsibility for marketing activities, ideally for payers, HCPs, and reimbursement audiences.
Ability to work cross-functionally to develop payer messaging, contracting strategy, build business cases, and develop training/communication plans for field teams
Knowledge of standard Payer research methodologies, financial analyses, and gross-to-net dynamics
Excellent analytical, strategic thinking and critical thinking skills with the ability to translate data into strategy
Must be highly motivated with strong interpersonal and communications skills
Ability to develop and deliver clear, compelling presentations on complex pricing topics to senior-level executive audience
Ability to handle multiple tasks and effectively prioritize to meet individual and team goals.
Must be able to produce high quality, accurate work under time constraints.
Ability to build and maintain strong cross-functional and cross-team ties to influence colleagues.
Must have the ability to work effectively in a team environment
Additional Information
Base salary offered is determined through an analytical approach utilizing a combination of factors including, but not limited to, relevant skills & experience, job location, and internal equity.
Regular employees are eligible to receive both short term and long-term incentives, including cash bonus and equity incentive opportunities, designed to reward recent achievements and recognize your future potential based on individual, business unit and company performance.
In addition to compensation, Biogen offers a full and highly competitive range of benefits designed to support our employees’ and their families physical, financial, emotional, and social well-being; including, but not limited to:
Why Biogen?
We are a global team with a commitment to excellence, and a pioneering spirit. As a mid-sized biotechnology company, we provide the stability and resources of a well-established business while fostering an environment where individual contributions make a significant impact. Our team encompasses some of the most talented and passionate achievers who have unparalleled opportunities for learning, growth, and expanding their skills. Above all, we work together to deliver life-changing medicines, with every role playing a vital part in our mission. Caring Deeply. Achieving Excellence. Changing Lives.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about Biogen.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.
Website: https://www.biogen.com/
Headquarter Location: Cambridge, Massachusetts, United States
Employee Count: 5001-10000
Year Founded: 1978
IPO Status: Private
Industries: Biotechnology ⋅ Health Care ⋅ Life Science ⋅ Manufacturing ⋅ Medical ⋅ Precision Medicine ⋅ Therapeutics